Alison Evans

1.5k total citations
33 papers, 707 citations indexed

About

Alison Evans is a scholar working on Cardiology and Cardiovascular Medicine, Psychiatry and Mental health and Infectious Diseases. According to data from OpenAlex, Alison Evans has authored 33 papers receiving a total of 707 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Cardiology and Cardiovascular Medicine, 6 papers in Psychiatry and Mental health and 5 papers in Infectious Diseases. Recurrent topics in Alison Evans's work include Atrial Fibrillation Management and Outcomes (5 papers), Dementia and Cognitive Impairment Research (5 papers) and SARS-CoV-2 and COVID-19 Research (3 papers). Alison Evans is often cited by papers focused on Atrial Fibrillation Management and Outcomes (5 papers), Dementia and Cognitive Impairment Research (5 papers) and SARS-CoV-2 and COVID-19 Research (3 papers). Alison Evans collaborates with scholars based in United Kingdom, United States and Australia. Alison Evans's co-authors include Irene J Higginson, Lauren Rayner, Matthew Hotopf, Koravangattu Valsraj, Annabel Price, José Luís Molinuevo, Alireza Atri, Matthew Norton, Youssef El-Hayek and Ryan E. Wiley and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Cochrane Database of Systematic Reviews.

In The Last Decade

Alison Evans

31 papers receiving 684 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alison Evans United Kingdom 11 159 131 124 87 86 33 707
Boya Nugraha Germany 18 229 1.4× 215 1.6× 100 0.8× 87 1.0× 52 0.6× 70 921
Pierre M. Bet Netherlands 19 174 1.1× 93 0.7× 66 0.5× 45 0.5× 62 0.7× 65 1.0k
Richa Sood United States 19 132 0.8× 139 1.1× 134 1.1× 59 0.7× 89 1.0× 40 934
Ruth Brauer United Kingdom 20 182 1.1× 128 1.0× 195 1.6× 41 0.5× 43 0.5× 47 1.1k
Xiaozhen Lv China 21 355 2.2× 228 1.7× 133 1.1× 154 1.8× 108 1.3× 80 1.4k
Amit Sood United States 13 87 0.5× 208 1.6× 95 0.8× 103 1.2× 104 1.2× 19 907
Chang Park United States 20 92 0.6× 142 1.1× 80 0.6× 108 1.2× 159 1.8× 70 1.1k
Hsing‐Hsia Chen Taiwan 18 66 0.4× 185 1.4× 136 1.1× 130 1.5× 43 0.5× 30 780
Anwar Mulugeta Ethiopia 16 92 0.6× 194 1.5× 162 1.3× 52 0.6× 32 0.4× 39 969
McKenzie Ferguson United States 14 144 0.9× 132 1.0× 91 0.7× 67 0.8× 71 0.8× 28 938

Countries citing papers authored by Alison Evans

Since Specialization
Citations

This map shows the geographic impact of Alison Evans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alison Evans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alison Evans more than expected).

Fields of papers citing papers by Alison Evans

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alison Evans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alison Evans. The network helps show where Alison Evans may publish in the future.

Co-authorship network of co-authors of Alison Evans

This figure shows the co-authorship network connecting the top 25 collaborators of Alison Evans. A scholar is included among the top collaborators of Alison Evans based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alison Evans. Alison Evans is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Evans, Alison, et al.. (2025). Safety and utilisation of AZD1222 (ChAdOx1 nCoV-19) COVID-19 vaccine: a UK post-authorisation active surveillance study. BMJ Open. 15(5). e093366–e093366. 1 indexed citations
2.
Hopewell, Sally, Cynthia Srikesavan, Alison Evans, et al.. (2024). Anti-TNF (adalimumab) injection for the treatment of pain-predominant early-stage frozen shoulder: the Anti-Freaze-Feasibility randomised controlled trial. BMJ Open. 14(5). e078273–e078273. 1 indexed citations
3.
4.
Kaplan, Sigal, Monica L. Bertoia, Florence T. Wang, et al.. (2021). Long-term safety of extended levonorgestrel-containing oral contraceptives in the United States. Contraception. 105. 26–32. 2 indexed citations
5.
Evans, Alison, et al.. (2021). A Systematic Review of Flurbiprofen 8.75 mg Dose and Risk of Haemorrhagic Events. Frontiers in Pharmacology. 12. 726141–726141. 6 indexed citations
6.
Rodrı́guez, Luis A. Garcı́a, Mari‐Ann Wallander, Leif Friberg, et al.. (2020). Rationale and design of a European epidemiological post-authorization safety study (PASS) program: rivaroxaban use in routine clinical practice. Expert Opinion on Drug Safety. 19(11). 1513–1520. 4 indexed citations
7.
Osborne, Vicki, et al.. (2020). Remdesivir in Treatment of COVID-19: A Systematic Benefit–Risk Assessment. Drug Safety. 43(7). 645–656. 43 indexed citations
8.
9.
10.
Osborne, Vicki, et al.. (2020). Observational assessment of safety in seroquel (OASIS): a specialist cohort event monitoring (SCEM) study in England. SHILAP Revista de lepidopterología. 10. 3628520184–3628520184. 1 indexed citations
11.
El-Hayek, Youssef, Ryan E. Wiley, Ritesh P. Daya, et al.. (2019). Tip of the Iceberg: Assessing the Global Socioeconomic Costs of Alzheimer’s Disease and Related Dementias and Strategic Implications for Stakeholders. Journal of Alzheimer s Disease. 70(2). 323–341. 157 indexed citations
12.
13.
Muñiz‐Terrera, Graciela, Julie Watson, Charlotte Clarke, et al.. (2018). Participant outcomes and preferences in Alzheimer's disease clinical trials: The electronic Person‐Specific Outcome Measure (ePSOM) development program. Alzheimer s & Dementia Translational Research & Clinical Interventions. 4(1). 694–702. 13 indexed citations
14.
Evans, Alison. (2012). Nutrition screening in patients with COPD.. PubMed. 108(11). 12–4. 3 indexed citations
15.
Evans, Alison, Graham Hart, Richard Mole, et al.. (2011). Central and East European migrant men who have sex with men in London: a comparison of recruitment methods. BMC Medical Research Methodology. 11(1). 69–69. 12 indexed citations
16.
Price, Amy, Lauren Rayner, Alison Evans, et al.. (2011). Antidepressants for the treatment of depression in neurological disorders: a systematic review and meta-analysis of randomised controlled trials. Journal of Neurology Neurosurgery & Psychiatry. 82(8). 914–923. 59 indexed citations
17.
Rayner, Lauren, Annabel Price, Alison Evans, et al.. (2010). Antidepressants for the treatment of depression in palliative care: systematic review and meta-analysis. Palliative Medicine. 25(1). 36–51. 109 indexed citations
18.
Evans, Alison, Violetta Parutis, Graham Hart, et al.. (2009). The sexual attitudes and lifestyles of London's Eastern Europeans (SALLEE Project): design and methods. BMC Public Health. 9(1). 399–399. 17 indexed citations
19.
Evans, Alison, Richard D. Wiggins, Graham Bolding, & Jonathan Elford. (2008). Characteristics of Gay and Bisexual Men Who Drop Out of a Web Survey of Sexual Behaviour in the UK. AIDS and Behavior. 12(6). 957–963. 4 indexed citations
20.
Pantin, C. F. A., et al.. (1993). Computers in respiratory medicine.. PubMed. 48(10). 656–9, 662. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Boya Nugraha Breakdown of academic impact, for papers by Pierre M. Bet Breakdown of academic impact, for papers by Richa Sood Breakdown of academic impact, for papers by Ruth Brauer Breakdown of academic impact, for papers by Xiaozhen Lv Breakdown of academic impact, for papers by Amit Sood Breakdown of academic impact, for papers by Chang Park Breakdown of academic impact, for papers by Hsing‐Hsia Chen Breakdown of academic impact, for papers by Anwar Mulugeta Breakdown of academic impact, for papers by McKenzie Ferguson
Rankless by CCL
2026